Assessment of a psychosocial intervention to prevent depression and anxiety in elderly people who attend primary health care centers

Assessment of a psychosocial intervention to prevent depression and anxiety in elderly people who attend primary health care centers: A clinical randomized trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN32235611

Enrollment

340

Registered

2018-07-25

Start date

2018-08-01

Completion date

Unknown

Last updated

2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression and anxiety Mental and Behavioural Disorders Depression and anxiety

Interventions

Those who accept the invitation to participate in the study will receive the initial assessment and those who meet participant exclusion criteria will be identified. The initial assessment includes so

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 65-80 years 2. Self-reliant 3. Health center user

Exclusion criteria

Exclusion criteria: 1. Diagnosis of common psychiatric disorder (e.g. depressive or anxiety disorder) 2. Diagnosis of severe mental disorder 3. Physical disability 4. Disability that limits and/or prevents communication

Design outcomes

Primary

Measure	Time frame
Depressive symptomatology will be assessed using the Patient Health Questionnaire (PHQ-9) (Baader et al., 2012; Kroenke, Spitzer, & Williams, 2001) before the intervention (pretest 3-4 weeks prior to the intervention), 18 weeks after the intervention (first post test) and 36 weeks after the intervention (second post test).	—

Secondary

Measure	Time frame
The following will be assessed before the intervention (pretest 3-4 weeks prior to the intervention), 18 weeks after the intervention (first post test) and 36 weeks after the intervention (second post test): 1. Anxiety symptomatology will be assessed with the anxiety subscale of the Symptom Check List (SCL-90-R) (Derogatis & Cleary, 1977; Gempp & Avendaño, 2008) 2. Depressive disorder will be assessed using Module E of the Composite International Diagnostic Interview (CIDI 2.1) (WHO, 1997) 3. Anxiety disorder (panic disorder and generalized anxiety disorder) will be assessed using the anxious disorders section of the Mini-International Neuropsychiatry Interview (MINI) (Sheehan, Lecrubier, Sheehan, Amorim, Janavs et al., 1999, Ferrando, Franco- Alfonso, Soto, Bobes García, Soto et al., 2000). 4. Psychological wellbeing will be assessed using the Pemberton Happiness Index (Hervás & Vázquez, 2013)	—

Measure

Time frame

The following will be assessed before the intervention (pretest 3-4 weeks prior to the intervention), 18 weeks after the intervention (first post test) and 36 weeks after the intervention (second post test): 1. Anxiety symptomatology will be assessed with the anxiety subscale of the Symptom Check List (SCL-90-R) (Derogatis & Cleary, 1977; Gempp & Avendaño, 2008) 2. Depressive disorder will be assessed using Module E of the Composite International Diagnostic Interview (CIDI 2.1) (WHO, 1997) 3. Anxiety disorder (panic disorder and generalized anxiety disorder) will be assessed using the anxious disorders section of the Mini-International Neuropsychiatry Interview (MINI) (Sheehan, Lecrubier, Sheehan, Amorim, Janavs et al., 1999, Ferrando, Franco- Alfonso, Soto, Bobes García, Soto et al., 2000). 4. Psychological wellbeing will be assessed using the Pemberton Happiness Index (Hervás & Vázquez, 2013)

—

Countries

Chile

Contacts

Public ContactSandra Saldivia

ssaldivi@udec.cl56-41-2204299

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 2, 2026